SB-216641
SB-216641 is a compound that is used in scientific research. It acts as a selective antagonist for the 5-HT1B receptor, which is a subtype of the 5-HT receptor that binds to the neurotransmitter serotonin. SB-216641 is used to study the role of 5-HT1B receptors in various processes including anxiety, depression, and drug addiction.
Pharmacology[edit | edit source]
SB-216641 is a potent and selective antagonist for the 5-HT1B receptor. It has a high affinity for this receptor subtype, with a Ki value of 1.4 nM. This makes it a useful tool for studying the role of 5-HT1B receptors in the brain and other tissues.
Uses in Research[edit | edit source]
SB-216641 has been used in a variety of research studies to investigate the role of 5-HT1B receptors in different physiological and pathological processes. These include studies on anxiety, depression, drug addiction, and migraine.
Anxiety and Depression[edit | edit source]
Research has shown that 5-HT1B receptors play a role in the regulation of mood and anxiety. SB-216641 has been used in animal models to investigate this role further. For example, it has been shown that administration of SB-216641 can increase anxiety-like behavior in rats, suggesting that 5-HT1B receptors may have an anxiolytic effect.
Drug Addiction[edit | edit source]
SB-216641 has also been used to study the role of 5-HT1B receptors in drug addiction. Studies have shown that these receptors may be involved in the reinforcing effects of drugs of abuse, such as cocaine and amphetamines. SB-216641 has been used to investigate this role further.
Migraine[edit | edit source]
5-HT1B receptors are thought to be involved in the pathophysiology of migraine. SB-216641 has been used in research to investigate this role further. For example, it has been shown that administration of SB-216641 can inhibit the vasodilation that is associated with migraine, suggesting that 5-HT1B receptors may be a potential target for the treatment of this condition.
See Also[edit | edit source]
| SB-216641 Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
